PMID

Data

Article Title

Organization

SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR¿ Inhibitor.

Central Pharmaceutical Research Institute

Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.

Boehringer Ingelheim Pharmaceuticals

Synthesis and biological action of two glucocorticoid alkylating agents.

TBA

Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.

Schering

Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy.

Merck Research Laboratories

Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.

Taisho Pharmaceutical